Lv6
2370 积分 2022-06-10 加入
The Pyruvate Kinase Activator Etavopivat (FT-4202) Limits Pulmonary and Systemic Sequelae of Sepsis in a Mouse LPS Model
15小时前
已关闭
Discovery of the First Highly Potent, Selective, Irreversible Small-Molecule Factor XIIa Inhibitor for Treating Sepsis
3天前
已完结
Pharmacokinetics, Disposition, and Biotransformation of Laroprovstat in Humans: In Vivo and In Vitro Evaluations
4天前
已完结
Phase 3 study results for oral PCSK9 inhibition with enlicitide
6天前
已完结
Proprotein convertase subtilisin/kexin Type 9 inhibitors: past, present, and future
26天前
已完结
Diagnosis and management of pyruvate kinase deficiency: international expert guidelines
1个月前
已完结
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial
1个月前
已完结
Sickle-cell disease
1个月前
已完结
Global, regional, and national burden of thalassemia during 1990‐2019: A systematic analysis of the Global Burden of Disease Study 2019
1个月前
已完结
皖公网安备34019202002308
